Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.

Snee LS, Nerurkar VR, Dooley DA, Efird JT, Shovic AC, Nerurkar PV.

Nutr J. 2011 Jul 28;10:78. doi: 10.1186/1475-2891-10-78. Erratum in: Nutr J. 2014;13:3.

2.

Bitter melon (Momordica charantia): a review of efficacy and safety.

Basch E, Gabardi S, Ulbricht C.

Am J Health Syst Pharm. 2003 Feb 15;60(4):356-9. Review.

PMID:
12625217
3.

Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.

Inayat-ur-Rahman, Malik SA, Bashir M, Khan R, Iqbal M.

Phytomedicine. 2009 May;16(5):401-5. doi: 10.1016/j.phymed.2009.01.001. Epub 2009 Apr 10.

PMID:
19362455
4.

Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.

Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, Ingkaninan K, Plianbangchang P, Haines ST.

J Ethnopharmacol. 2011 Mar 24;134(2):422-8. doi: 10.1016/j.jep.2010.12.045. Epub 2011 Jan 4.

PMID:
21211558
5.

Momordica charantia and type 2 diabetes: from in vitro to human studies.

Habicht SD, Ludwig C, Yang RY, Krawinkel MB.

Curr Diabetes Rev. 2014 Jan;10(1):48-60. Review.

PMID:
24295371
6.

Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.

Shih CC, Lin CH, Lin WL, Wu JB.

J Ethnopharmacol. 2009 May 4;123(1):82-90. doi: 10.1016/j.jep.2009.02.039. Epub 2009 Mar 6.

PMID:
19429344
7.

Momordica charantia for type 2 diabetes mellitus.

Ooi CP, Yassin Z, Hamid TA.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007845. doi: 10.1002/14651858.CD007845.pub3. Review.

PMID:
22895968
8.

Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.

Yang SJ, Choi JM, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY.

J Nutr Biochem. 2015 Mar;26(3):234-40. doi: 10.1016/j.jnutbio.2014.10.010. Epub 2014 Nov 22.

PMID:
25488547
9.

Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.

Shetty AK, Kumar GS, Sambaiah K, Salimath PV.

Plant Foods Hum Nutr. 2005 Sep;60(3):109-12.

PMID:
16187012
10.

Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.

Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S.

Br J Nutr. 2009 Dec;102(12):1703-8. doi: 10.1017/S0007114509992054. Review.

PMID:
19825210
11.

Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Inayat U Rahman, Khan RU, Khalil Ur Rahman, Bashir M.

Nutr J. 2015 Jan 26;14:13. doi: 10.1186/1475-2891-14-13.

12.

Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.

Jayasooriya AP, Sakono M, Yukizaki C, Kawano M, Yamamoto K, Fukuda N.

J Ethnopharmacol. 2000 Sep;72(1-2):331-6.

PMID:
10967491
13.

Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.

Wang HY, Kan WC, Cheng TJ, Yu SH, Chang LH, Chuu JJ.

Food Chem Toxicol. 2014 Jul;69:347-56. doi: 10.1016/j.fct.2014.04.008. Epub 2014 Apr 18.

PMID:
24751968
14.

Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.

Krawinkel MB, Keding GB.

Nutr Rev. 2006 Jul;64(7 Pt 1):331-7. Review.

PMID:
16910221
15.

The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.

Senanayake GV, Maruyama M, Shibuya K, Sakono M, Fukuda N, Morishita T, Yukizaki C, Kawano M, Ohta H.

J Ethnopharmacol. 2004 Apr;91(2-3):257-62.

PMID:
15120448
16.

Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients.

Ahmad N, Hassan MR, Halder H, Bennoor KS.

Bangladesh Med Res Counc Bull. 1999 Apr;25(1):11-3.

PMID:
10758656
17.

Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.

Czompa A, Gyongyosi A, Szoke K, Bak I, Csepanyi E, Haines DD, Tosaki A, Lekli I.

Molecules. 2017 Mar 20;22(3). pii: E488. doi: 10.3390/molecules22030488.

18.

Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Raina K, Kumar D, Agarwal R.

Semin Cancer Biol. 2016 Oct;40-41:116-129. doi: 10.1016/j.semcancer.2016.07.002. Epub 2016 Jul 21. Review.

PMID:
27452666
19.

Momordica charantia (bitter melon). Monograph.

[No authors listed]

Altern Med Rev. 2007 Dec;12(4):360-3. No abstract available.

20.

Antihyperglycemic effects of three extracts from Momordica charantia.

Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK.

J Ethnopharmacol. 2003 Sep;88(1):107-11.

PMID:
12902059

Supplemental Content

Support Center